Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
8.50
-0.19 (-2.19%)
At close: Jul 15, 2025, 4:00 PM
8.33
-0.17 (-2.00%)
After-hours: Jul 15, 2025, 5:53 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $51.98 million as of July 15, 2025. Its market cap has increased by 66.94% in one year.
Market Cap
51.98M
Enterprise Value
-78.01M
1-Year Change
66.94%
Ranking
Category
Stock Price
$8.50
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $51.98M, a decrease of -90.61%. That is a compound annual growth rate of -39.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 53.14M | -64.06% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |